Migraine and the menopause

Journal of the British Menopause Society

Volumn 12, Issue 3, 2006, Pages 104-108

  MacGregor, E Anne ^a  

^a City of London Migraine Clinic   (United Kingdom)

Author keywords

Estrogen; Hormone replacement therapy; Menopause; Migraine; Stroke

Indexed keywords

ANALGESIC AGENT; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; DYDROGESTERONE; ESTRADIOL; ESTRADIOL ENANTHATE; ESTROGEN; ESTRONE; ETHINYLESTRADIOL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROGESTERONE DERIVATIVE; TESTOSTERONE DERIVATIVE;

BREAST TENDERNESS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; EMBASE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ESTROGEN THERAPY; FEMALE; FLUID RETENTION; HEADACHE; HOT FLUSH; HUMAN; HYSTERECTOMY; INFORMATION RETRIEVAL; LEG CRAMP; LOW DRUG DOSE; MEDICAL INFORMATION; MEDLINE; MENOPAUSAL SYNDROME; MENOPAUSE; MENSTRUAL IRREGULARITY; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NAUSEA; OVARIECTOMY; POSTMENOPAUSE; PREMENSTRUAL SYNDROME; REVIEW; SEDATION; SIDE EFFECT; TREATMENT CONTRAINDICATION;

CEREBROVASCULAR ACCIDENT; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIGRAINE DISORDERS; PROGESTINS;

EID: 33748870724     PISSN: 13621807     EISSN: 13621807     Source Type: Journal    
DOI: 10.1258/136218006778234048     Document Type: Review

References (47)

1. Bille B. Migraine in school children. Acta Paed Scand 1962;51 (suppl 136):1-151
2. Scher A, Stewart W, Lipton R. Migraine and headache: a meta-analytic approach. In: Crombie I, ed. Epidemiology of Pain. Seattle: IASP Press, 1999
3. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267:64-9
4. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991;44:1147-57
5. MacGregor EA, Igarashi H, Wilkinson M. Headaches and hormones: subjective versus objective assessment. Headache Quarterly 1997;8:126-36
6. Couturier EG, Bomhof MAM, Neven AK, van Duijn NP. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003; 23:302-8
7. MacGregor EA, Frith A, Ellis J, Aspinall LJ, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and failing estrogen. Neurology 2006; in press
8. MacGregor EA, Hackshaw A. Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements. J Fam Plann Reprod Health Care 2002;28:27-31
9. MacGregor EA, Chia H, Vohrah RC, Wilkinson M. Migraine and menstruation: a pilot study. Cephalalgia 1990;10:305-10
10. Johannes C, Linet M, Stewart W, et al. Relationship of headache to the phase of the menstrual cycle among young women: a daily diary study. Neurology 1995;45:1076-82
11. Stewart W, Lipton R, Chee E, Sawyer J, Silberstein S. Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000;55:1517-23
12. Nagel-Leiby S, Welch KM, Grunfeld S, D'Andrea G. Ovarian steroid levels in migraine with and without aura. Cephalalgia 1990;10:147-52
13. Bickerstaff ER. Neurological Complications of Oral Contraceptives. Oxford: Oxford University Press, 1975
14. Granella F, Sances G, Pucci E, et al. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000; 20:701-7
15. MacGregor A. Estrogen replacement and migraine aura. Headache 1999;39:674-8
16. Kaiser HJ, Meienberg O. Deterioration of onset of migraine under oestrogen replacement therapy in the menopause. J Neurol Neurosurg Psychiatry 1993;240:195-7
17. Wang SJ, Fuh JL, Lu SR, et al. Migraine prevalence during menopausal transition. Headache 2003;43:470-8
18. Mueller L. Predictability of exogenous hormone effect on subgroups of migraineurs. Headache 2000;40:189-93
19. Granella F, Sances G, Zanferrari C, et al. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993;33:385-9
20. Neri I, Granella F, Nappi R, et al. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 1993;17:31-7
21. Mattsson P. Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache 2003;43:27-35
22. Oldenhave A, Jaszmann LJ, Everaerd WT, Haspels AA. Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obstet Gynecol 1993;168:765-71
23. Dennerstein L, Laby H, Burrows GD, Hyman GJ. Headache and sex hormone therapy. Headache 1978;18:146-53
24. Misakian AL, Langer KD, Bensenor IM, et al. Postmenopausal hormone therapy and migraine headache. J Womens Health (Larchmt) 2003;12:1027-36
25. Lichten EM, Lichten JB, Whitty A, Pieper D. The confirmation of a biochemical marker for women's hormonal migraine: the depot-estradiol challenge test. Headache 1996;36:367-71
26. Kudrow L. The relationship of headache frequency to hormone use in migraine. Headache 1975;15:36-40
27. Evans M, Fleming K, Evans J. Hormone replacement therapy: management of common problems. Mayo Clin Proc 1995;70: 800-5
28. MacGregor A. Effects of oral and transdermal estrogen replacement on migraine. Cephalalgia 1999;19:124-5
29. Nappi RE, Cagnacci A, Granella F, et al. Course of primary headaches during hormone replacement therapy. Maturitas 2001;38:157-63
30. Kuhl H. Pharmacokinetics of oestrogen and progestogens. Maturitas 1990;12:171-97
31. MacDonald PC, Edman CD, Hemsell DL, et al. Effect of obesity on conversion of plasma androstenedione to estrogen in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 1978;130:448-55
32. Magos A, Brewster E, Singh R, et al. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 1986;93:1290-6
33. Vestergaard P, Hermann PA, Gram J, et al. Improving compliance with hormonal replacement therapy in primary osteoporosis prevention. Maturitas 1997;28:137-45
34. Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997;3:159-71
35. Lane G, King R, Whitehead M. The effects of oestrogens and progestogens on endometrial biochemistry. In: Studd J, Whitehead M, eds. The Menopause. Oxford: Blackwell Scientific, 1988: 213-26
36. Hampton N, Rees MC, Barlow DH, et al. Levonorgestrel intra-uterine system (LNG IUS) with conjugated oral equine oestrogen: a successful regimen for hormonal replacement therapy in perimenopausal women. Hum Reprod 2005;20:2653-60
37. Facchinetti F, Nappi RE, Tirelli A, et al. Hormone supplementation differently affects migraine in postmenopausal women. Headache 2002;42:924-9
38. Tzourio C, Tehindrazanarivelo A, Iglesias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995;310:830-3
39. Carolei A, Marini C, de Matteis G, and the Italian National Research Council Study Group on Stroke in the Young. History of migraine and risk of cerebral ischaemia in young adults. Lancet 1996;347:1503-6
40. Chang C, Donaghy M, Poulter N, and World Health Organization Collaboration Study of Cardiovascular Disease and Steroid Hormone Contraception. Migraine and stroke in young women: case-control study. BMJ 1999;318:13-18
41. MacGregor EA, Guillebaud J. Clinical and Scientific Committee of the Faculty of Family Planning and Reproductive Health Care and the Family Planning Association. Combined oral contraceptives, migraine and ischaemic stroke. Br J Fam Plann 1998;24:55-60
42. World Health Organization. Medical Eligibility Criteria for Contraceptive Use. 3rd edn. Geneva: WHO, 2004
43. Bousser MG, Conard J, Kittner S, et al. International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. Cephalalgia 2000;20:155-6
44. Kurth T, Slomke MA, Kase CS, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005; 64:1020-6
45. Bousser MG, Conard J. TIAs, migraine and platelets. Headache 1987;27:522
46. MacGregor EA, Barnes D. Migraine in a specialist menopause clinic. Climacteric 1999;2:218-23
47. Hodson J, Thompson J, Al-Azzawi F. Headache at menopause and in hormone replacement therapy users. Climacteric 2000; 3:119-24